Stocks and InvestingStocks and Investing
Thu, March 8, 2018
Wed, March 7, 2018
Tue, March 6, 2018
Mon, March 5, 2018
Fri, March 2, 2018
Thu, March 1, 2018
Wed, February 28, 2018

Andrew Schenker Maintained (THC) at Sell with Increased Target to $16 on, Feb 28th, 2018


Published on 2024-10-26 03:24:17 - WOPRAI, Andrew Schenker
  Print publication without navigation


Andrew Schenker of Morgan Stanley, Maintained "Tenet Healthcare Corporation" (THC) at Sell with Increased Target from $15 to $16 on, Feb 28th, 2018.

Andrew has made no other calls on THC in the last 4 months.



There are 4 other peers that have a rating on THC. Out of the 4 peers that are also analyzing THC, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Credit Suisse" Initiated at Hold and Held Target at $15 on, Thursday, November 2nd, 2017


These are the ratings of the 3 analyists that currently disagree with Andrew


  • Gary Taylor of "JP Morgan" Downgraded from Hold to Sell on, Thursday, December 14th, 2017
  • Ralph Giacobbe of "Citigroup" Upgraded from Hold to Strong Buy on, Tuesday, December 12th, 2017
  • Brian Tanquilut of "Jefferies" Maintained at Strong Buy with Decreased Target to $20 on, Monday, October 30th, 2017